Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

✍ Scribed by Boscaro, M.; Ludlam, W. H.; Atkinson, B.; Glusman, J. E.; Petersenn, S.; Reincke, M.; Snyder, P.; Tabarin, A.; Biller, B. M. K.; Findling, J.; Melmed, S.; Darby, C. H.; Hu, K.; Wang, Y.; Freda, P. U.; Grossman, A. B.; Frohman, L. A.; Bertherat, J.

• Book ID: 121816203
• Publisher: Endocrine Society
• Year: 2009
• Tongue: English
• Weight: 142 KB
• Volume: 94
• Category: Article
• ISSN: 0021-972X
• DOI: 10.1210/jc.2008-1008